ketoconazole has been researched along with Liver Steatosis in 3 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolts, BE | 1 |
| Langfitt, M | 1 |
| Ritchie, DJ | 1 |
| Gradon, JD | 1 |
| Sepkowitz, DV | 1 |
3 other studies available for ketoconazole and Liver Steatosis
| Article | Year |
|---|---|
Drugs and the liver.
Topics: Acetaminophen; Adult; Aspirin; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liv | 1984 |
Comment: consideration of amphotericin B hepatotoxicity.
Topics: Amphotericin B; Fatty Liver; Hepatomegaly; Humans; Ketoconazole | 1991 |
Massive hepatic enlargement with fatty change associated with ketoconazole.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Fatty Liver; Female; | 1990 |